Table 2 Characteristics of included patients
Patients (N = 590) | Percentage (%) | |
|---|---|---|
Gender | ||
Female | 215 | 36.4 |
Age | ||
Less than 60 | 166 | 28.1 |
60 ~ 79 | 133 | 22.5 |
More than 80 | 291 | 49.3 |
History of disease | ||
Liver disease | 41 | 6.9 |
Renal disease | 3 | 0.5 |
Heart disease | 337 | 57.1 |
Metastatic malignancy | 6 | 1 |
Presenting symptoms | ||
Melena | 288 | 48.8 |
Hematemesis | 147 | 24.9 |
Hematochezia | 135 | 22.9 |
Syncope | 20 | 3.4 |
Medication | ||
No | 272 | 46.1 |
Aspirin or other antiplatelet such as clopidogrel | 202 | 34.2 |
Warfarin and other anticoagulant | 90 | 15.3 |
NSAIDs | 26 | 4.4 |
Time for endoscopic examination | ||
Less than 6 h | 233 | 39.5 |
6 ~ 24 h | 208 | 35.3 |
24 ~ 48 h | 143 | 24.2 |
After 48 h | 4 | 0.7 |
No endoscopy | 2 | 0.3 |
Transfusion | ||
No | 141 | 23.9 |
Yes | 449 | 76.1 |
Hemostatic procedures | ||
No | 386 | 65.4 |
Endoscopic intervention | 191 | 32.4 |
Radiologic intervention | 13 | 2.2 |
Surgery | 0 | 0 |
30-day mortality | ||
Survival | 565 | 95.8 |
Death | 25 | 4.2 |